Sources of variability and effect of experimental approach on expression profiling data interpretationEndothelial cell activation and neovascularization are prominent in dermatomyositisSexual dimorphism in immune response genes as a function of puberty.Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathiesDaily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositisThe TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug developmentFunctional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular DystrophyCharacterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotypePlatelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockadeGlucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouseVBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in miceGlycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzymeNon-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficitsImmunoblotting of single cell types isolated from frozen sections by laser microdissection.NKG2A inhibits TH2 cell effector function in vitro.Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophyImproving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy.The effects of MyD88 deficiency on disease phenotype in dysferlin-deficient A/J mice: role of endogenous TLR ligands.Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic targetVBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid.Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis.Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx micePreclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.GREG cells, a dysferlin-deficient myogenic mouse cell lineLosartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice.Time series proteome profiling to study endoplasmic reticulum stress response.Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsPolymyositis and dermatomyositis: pathophysiology.A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.Mitotic asynchrony induces transforming growth factor-β1 secretion from airway epitheliumIL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse.Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy.Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease.Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy.One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice.Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy
P50
Q24802502-A13F57EF-19DE-4A86-9361-1A97D1FC09EAQ25256876-FEDFDB69-1C9A-4EC5-877F-E0608E20501AQ25257034-8B95B743-FA76-40A2-A1F4-A807A0B6F20BQ26830775-110C1864-CEC9-4398-A0EE-9FEE41072E76Q27315915-F4CD9E29-1075-46C1-BFBC-B408214B704DQ28088277-0A45D708-31DC-404D-9907-E5E7C39E984AQ28474542-2AD587FB-CE7A-48DF-81DC-FC6827B5C3CEQ28475580-29909090-162D-42CE-B6F5-F40EED931EBDQ28481577-F0DF28C6-EC76-42E9-87EF-7422C3F72F83Q28482090-B3191454-79FC-47BF-A963-8FAA047BF074Q28487685-B8941930-2069-4394-898E-B5BAAF4C5268Q28511802-CFE9A24B-8E67-4143-95E4-5B7D971E8D77Q28544896-D6724F8B-3E50-4659-9A44-F7559F445A0DQ30868557-3901FA99-E8F6-4D99-99F7-E0092702B2EEQ33302211-5C7C1FE2-8D86-4797-87C1-800CDD30979BQ33529003-5783728A-A010-4EB2-BB4B-4E53DE21535FQ33649312-7ECA52CC-5B24-42D0-BF83-FB168B957A27Q33787898-C192BC28-7FAF-40BC-9686-AAB81DAF353EQ33808490-0461633B-6299-4A6C-BB0F-691FB2E91576Q33842215-C821DA53-F834-44F8-834E-E7EE2B6429C8Q33870621-68E0B6E3-EF82-4E2A-97A7-64825CE6B424Q33880537-3A6EFDEA-6CDD-4E86-A005-6132743F3521Q33882512-831230E2-7517-4DF4-99E2-7CAB4474397AQ33901556-BA9998D1-87CA-41D5-AF95-1B92166DD1AAQ33925571-9AAF5B18-08CB-4E03-A65A-B2AC4A26DFB0Q33975979-224F77E8-7C7E-4F9E-BBEA-81755192198BQ34054658-DBD2F996-CD9B-4EB5-A285-F47933FB15F4Q34103278-80328CC3-E2E4-4433-9365-A7DB722E7CADQ34132980-B1A309A3-D892-4E99-BF54-3846BF9C18D8Q34152280-6AE04F10-E641-4F86-9964-3D23590990E0Q34173868-89466180-92A7-4743-96B8-F91C19F82328Q34274225-96856799-549B-4690-8310-BA9672614AA3Q34305568-1D0F5CD1-19AD-4C29-9710-5A7AFCC7502AQ34310898-256BD5DD-D3E4-4EA8-A4CC-02D02C94E01AQ34332718-7C6AD643-ECFE-4F45-9E34-F233EC17E72BQ34555477-782AED02-D879-415D-9BEE-CD17529DAB82Q34577206-B4270862-6B2F-413B-A4EC-4B238D7726FFQ34580135-ED0A434F-A08C-4638-9FB6-3F6591FA2F89Q34621772-6B016607-70B1-4686-8ADA-4260A4D5AECDQ34769964-2E9D5C49-909D-4068-8B54-3E777B41A7B5
P50
description
immunoloog
@nl
name
Kanneboyina Nagaraju
@ast
Kanneboyina Nagaraju
@en
Kanneboyina Nagaraju
@es
Kanneboyina Nagaraju
@nl
type
label
Kanneboyina Nagaraju
@ast
Kanneboyina Nagaraju
@en
Kanneboyina Nagaraju
@es
Kanneboyina Nagaraju
@nl
prefLabel
Kanneboyina Nagaraju
@ast
Kanneboyina Nagaraju
@en
Kanneboyina Nagaraju
@es
Kanneboyina Nagaraju
@nl